Glossary

Impurity

Unintended component
Illustration

Any component of an API or a finished product that is not the intended active ingredient or excipient.

Source · MFDS, 「알기 쉬운 GMP 용어집」, Impurity Korean original

Related sections

Related terms

Real inspection findings

Findings from regulators' inspection documents in which this term appears.

  1. Specifically, you failed to perform microbial testing and impurity…
    FDA · FDA Warning Letter · 2023-02-14
  2. Your (b)(4) process for the manufacture of the API (b)(4) and (b)(4) results in quantifiable levels of (b)(4) Impurity (b)(4) at an irregular frequency.
    FDA · FDA Warning Letter · 2022-11-01
  3. All drugs from (b)(4) , FEI (b)(4) , were listed on IA 66-40 on (b)(4) , and the firm was issued a warning letter on (b)(4) , for among other things, inadequate impurity testing, and lack of audit trails to support CGMP activities.
    FDA · FDA Warning Letter · 2021-01-27
See 24 findings whose text contains this term

Counted as of 2026-09-24 — the search you land on shows today's figures, so it may differ slightly.

Source

MFDS, 「알기 쉬운 GMP 용어집」, Impurity Korean original

GRM Regulatory Glossary

243 GMP terms in one place

Each term is explained in plain language with its official source. Look it up here whenever you meet a term you don't know.

Browse the whole glossary
Weekly Newsletter

New GMP inspection findings, every Monday

Every Monday we email the week's new inspection records from the FDA, EMA, Health Canada and MFDS, with a short summary of the week's regulatory news. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.